Clover Health Investments, Corp CLOV
$4.15
+1.22%
at last close
Market Cap$2.18 billion
P/E Ratio—
Div Yield—
Volume2.72M
52-Week Range
$1.58$5.59
Analyst Ratings
- Consensus
- Hold — 1 Buy · 2 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $4.33 (+4.4% upside)
Key Stats
- Today's Range
- $4.08 – $4.18
- 50-Day Range
- $4.08 – $5.59
- 52-Week Range
- $1.58 – $5.59
- Volume
- 2.72 million shs
- Average Volume
- 4.44 million shs
- Market Cap
- $2.18 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.79
- Price / Sales
- 0.88
Short Interest
- Short Interest
- 2.09%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $2.48 billion
- Net Income
- $-18,362,000
- Net Margin
- -0.74%
- Return on Equity
- -4.88%
- Debt-to-Equity
- —
About Clover Health Investments, Corp
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Related Stocks
Compare head-to-head: CLOV vs UNH·CLOV vs CI·CLOV vs MOH·CLOV vs ALHC
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.